Variant Bio
Focus: Variant Bio is a Seattle-based genomic drug discovery company focused on oncology. Limited public data suggests early-stage operations with minimal commercial presence.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
1+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Variant Bio?
AI assessmentVariant Bio represents a speculative early-stage genomic oncology play suitable only for mission-driven scientists willing to accept high execution risk for potential upside.
Why Work Here
- Genomic drug discovery platform offers exposure to cutting-edge precision oncology technology
- Early-stage company provides opportunity for significant scientific and career impact in a lean environment
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Epidemiological study
GoutClinical Trials (1)
NCT04900090Tahiti-families: Polynesian Families of Gout Patients
N/AHelp build intelligence for Variant Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.